Marchex, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MCHX research report →
Price Chart
About the company
Marchex, Inc. is an analytical technology and solutions company that assists businesses throughout the United States and Canada in optimizing their customer acquisition journey. The company empowers clients to connect with, engage, measure, and successfully convert callers into customers.
- CEO
- Russell C. Horowitz
- IPO
- 2004
- Employees
- 139
- HQ
- Seattle, WA, US
Get TickerSpark's AI analysis on MCHX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $56.71M
- P/E
- -10.16
- Fwd P/E
- 32.00
- PEG
- 0.52
- P/S
- 1.29
- P/B
- 1.94
- EV/EBITDA
- -14.36
- Div Yield
- 0.00%
- Gross Margin
- 61.21%
- Op Margin
- -8.34%
- Net Margin
- -12.43%
- ROE
- -18.24%
- ROIC
- -12.06%
Latest fiscal year · YoY change
- Revenue
- $45.42M-5.6%
- Gross Profit
- $28.70M-7.3%
- Op Income
- $-4,374,000
- Net Income
- $-5,235,000-5.8%
- EPS
- $-0.12-9.1%
- OCF Growth
- -27.5%
- FCF Growth
- +5.8%
- 52W High
- $2.04
- 52W Low
- $1.15
- 50D MA
- $1.62
- 200D MA
- $1.62
- Beta
- 1.86
- RSI (14)
- 35
- Avg Volume
- 32.93K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Marchex reported modest Q2 revenue growth, closed Archenia, and said the combined AI platform is already creating larger cross-sell opportunities and a stronger 2026 outlook.· August 12, 2026
- Q2 2026 revenue was $11.0 million, up from $10.6 million in Q1 2026.
- The company closed the Archenia acquisition on July 1, but Q2 results did not include Archenia.
- Management is seeing early wins from bundled AI products, including paid pilots and customer expansions that can more than double annualized revenue at some accounts.
- Q3 2026 guidance calls for revenue of $16.0 million to $16.5 million and adjusted EBITDA of $2.3 million to $2.5 million.
- Management emphasized margin improvement, a lower cost structure, and selective reinvestment to support 2027 growth opportunities.
Second-quarter 2026 revenue was $11 million, compared with $10.6 million in the first quarter of 2026. The company did not provide EPS or gross margin figures on the call. Cash at the end of Q2 was $8.2 million, down from $9.0 million at the end of Q1, mainly due to transaction expenses, organizational realignment, and other efficiency initiatives. For Q3 2026, Marchex expects revenue of $16.0 million to $16.5 million and adjusted EBITDA of $2.3 million to $2.5 million. Management said Q3 will include a full quarter of Archenia, and that the sequential revenue increase should reflect both Archenia and continued growth in Marchex’s existing business.
Russell Horowitz framed the Archenia deal as a strategic shift from selling insights alone to selling insights plus automated actions and measurable outcomes. He repeatedly highlighted bundled AI solutions, saying they can expand wallet share, create larger deal sizes, and unlock significant untapped opportunity in the existing customer base and current verticals. His tone was upbeat and confident, but he also stressed execution discipline, recurring revenue conversion, and selective investment rather than broad spending.
Brian Nagle said revenue grew to $11 million in Q2 from $10.6 million in Q1, helped by new sales and upsells. He pointed to operating expense efficiencies from organizational realignment, offset somewhat by acquisition-related costs tied to Archenia’s closing. He also said the company ended Q2 with $8.2 million in cash versus $9.0 million in Q1, and that the lower cost structure should support improving margins and future operating leverage as new products sell through.
Analysts focused on pipeline quality, deal size, cross-sell momentum, and capital allocation. Management said there is a double-digit number of customers with potential for $1 million or more of incremental revenue, and many of those could eventually become multi-million-dollar annual opportunities. On buybacks and reinvestment, management said it will evaluate the best use of cash over time, noted the business is low-CapEx with meaningful tax shields, and reminded investors that a 3 million share repurchase authorization remains in place.
The bull case is that Archenia materially expands Marchex’s product set from analytics to outcomes, which management believes can drive much larger customer budgets. Early examples already show meaningful expansion at existing customers, and management said the company has a double-digit number of $1 million-plus opportunities in the pipeline. The higher revenue run rate, lower cost structure, and improving adjusted EBITDA margin could create operating leverage.
The main risks are execution and timing: management said the strategy is still early, many products are in development or pilot stages, and conversion from pilot to broader deployment is not assured. Q2 cash declined, and the company is still absorbing acquisition and realignment costs. Management also acknowledged that the path to the $100 million-plus target and Rule of 30 to 40 trajectory depends on successfully proving measurable customer value and converting that into recurring revenue.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.8%
- Shares Outstanding
- 44.30M
- Float Shares
- 36.23M
of shares held by institutions
28 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Edenbrook Capital, LLC | 14.66M | 0 |
| Renaissance Technologies LLC | 1.58M | ▼ 29.44K |
| Kanen Wealth Management LLC | 1.30M | 0 |
| Vanguard Group Inc | 1.29M | 0 |
| Vanguard Capital Management LLC | 1.08M | ▼ 1.46K |
| Blackrock, Inc. | 656.22K | ▲ 16.23K |
| Geode Capital Management, LLC | 400.63K | ▼ 4.18K |
| P.A.W. Capital Corp | 400.00K | 0 |
| Vanguard Fiduciary Trust Co | 203.63K | ▲ 1.46K |
| Acadian Asset Management LLC | 185.45K | ▼ 26.17K |
| Srs Capital Advisors, Inc. | 145.91K | ▲ 145.91K |
| State Street Corp | 140.70K | 0 |
Held by 27 ETFs
Biggest fund positions in MCHX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | HOROWITZ RUSSELL C | other | 0 |
| Jul 1, 26 | ARENDS MICHAEL A | other | 0 |
| Mar 20, 26 | HARTLESS TROY | other | 87,500 |
| Mar 20, 26 | HARTLESS TROY | other | 87,500 |
| Mar 20, 26 | Nagle Brian | other | 7,500 |
| Mar 20, 26 | Nagle Brian | other | 7,500 |
| Mar 20, 26 | Feeney Francis J | other | 62,500 |
| Mar 20, 26 | Feeney Francis J | other | 62,500 |
| Feb 17, 26 | Nagle Brian | other | 56,089 |
| Feb 17, 26 | HARTLESS TROY | other | 128,205 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MCHX coverage
Recent articles, reports, and earnings notes.
No research on MCHX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MCHX report →Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach
globenewswire.com · Sep 22
Analyzing Marchex (NASDAQ:MCHX) and Tuya (NYSE:TUYA)
defenseworld.net · Sep 21
Marchex Expands Existing Customer Relationship with Commercial Deployment of AI Voice Agent
globenewswire.com · Sep 16
Marchex, Inc. (MCHX) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 13
Marchex Q2 Earnings Call Highlights
marketbeat.com · Aug 12
Marchex Announces Second Quarter 2026 Financial Results
globenewswire.com · Aug 12
Marchex (NASDAQ:MCHX) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?
defenseworld.net · Aug 12
Marchex to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
globenewswire.com · Aug 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.